LGND Latest Press Releases

-- February 12, 2026 --

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 Globe Newswire 7:00 AM

-- February 4, 2026 --

Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 7:00 AM

-- December 9, 2025 --

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance Globe Newswire 7:00 AM

-- November 10, 2025 --

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates Globe Newswire 4:10 PM

-- November 7, 2025 --

Pelthos Therapeutics Acquires Xepi (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing Globe Newswire 8:00 AM

-- November 6, 2025 --

Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance Globe Newswire 7:00 AM

-- October 30, 2025 --

Ligand to Participate in November Investor Conferences Globe Newswire 4:01 PM

-- October 23, 2025 --

Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 Globe Newswire 7:00 AM

-- October 16, 2025 --

Ligand to Host Investor Day on December 9, 2025 Globe Newswire 7:00 AM

-- October 9, 2025 --

Ligand Partner SQ Innovation Receives FDA Approval for Lasix ONYU, an At-Home Treatment for Edema in Heart Failure Patients Globe Newswire 7:00 AM

-- September 25, 2025 --

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 Globe Newswire 2:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software